Nu Skin Enterprises Stock Profit Margin
| NUS Stock | USD 8.33 0.13 1.59% |
Fundamental analysis of Nu Skin allows traders to better anticipate movements in Nu Skin's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Nu Skin Enterprises Company Profit Margin Analysis
Nu Skin's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Nu Skin Profit Margin | (0.02) % |
Most of Nu Skin's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nu Skin Enterprises is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Nu Skin Enterprises has a Profit Margin of -0.023%. This is 100.76% lower than that of the Personal Care Products sector and 100.44% lower than that of the Consumer Staples industry. The profit margin for all United States stocks is 98.19% lower than that of the firm.
NUS Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nu Skin's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nu Skin could also be used in its relative valuation, which is a method of valuing Nu Skin by comparing valuation metrics of similar companies.Nu Skin is currently under evaluation in profit margin category among its peers.
NUS Fundamentals
| Return On Equity | -0.0493 | ||||
| Return On Asset | 0.0354 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 492.34 M | ||||
| Shares Outstanding | 49.41 M | ||||
| Shares Owned By Insiders | 2.23 % | ||||
| Shares Owned By Institutions | 75.78 % | ||||
| Number Of Shares Shorted | 1.98 M | ||||
| Price To Earning | 10.70 X | ||||
| Price To Book | 0.54 X | ||||
| Price To Sales | 0.24 X | ||||
| Revenue | 1.73 B | ||||
| Gross Profit | 1.17 B | ||||
| EBITDA | (78.83 M) | ||||
| Net Income | (146.59 M) | ||||
| Cash And Equivalents | 186.88 M | ||||
| Cash Per Share | 7.69 X | ||||
| Total Debt | 478.23 M | ||||
| Debt To Equity | 0.59 % | ||||
| Current Ratio | 2.30 X | ||||
| Book Value Per Share | 15.26 X | ||||
| Cash Flow From Operations | 111.74 M | ||||
| Short Ratio | 3.74 X | ||||
| Earnings Per Share | (0.80) X | ||||
| Price To Earnings To Growth | 2.35 X | ||||
| Target Price | 7.5 | ||||
| Number Of Employees | 3.1 K | ||||
| Beta | 0.93 | ||||
| Market Capitalization | 405.19 M | ||||
| Total Asset | 1.47 B | ||||
| Retained Earnings | 1.71 B | ||||
| Working Capital | 241.99 M | ||||
| Current Asset | 706.39 M | ||||
| Current Liabilities | 407.6 M | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 3.09 % | ||||
| Net Asset | 1.47 B | ||||
| Last Dividend Paid | 0.24 |
About Nu Skin Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nu Skin Enterprises's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nu Skin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nu Skin Enterprises based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.